Daniel Labow is an Oncology physician affiliated with Danbury Hospital. OpenAlex indexes 170 publications with 6,497 citations (h-index 35).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial
The Lancet. Gastroenterology & hepatology
2022 - Peritoneal Cancers and Hyperthermic Intraperitoneal Chemotherapy
Surgical Clinics of North America
2020 - Multiscale network analysis reveals molecular mechanisms and key regulators of the tumor microenvironment in gastric cancer
International Journal of Cancer
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Vincent Rella, MD
Danbury Hospital
Paul Iannini, MD
Danbury Hospital
Steven Brandwein, MD
Danbury Hospital
Robert Kapel, MD
Danbury Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”